Global Next Generation Sequencing Market Overview:
Global Next Generation Sequencing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Next Generation Sequencing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Next Generation Sequencing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Next Generation Sequencing Market:
The Next Generation Sequencing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Next Generation Sequencing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Next Generation Sequencing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Next Generation Sequencing market has been segmented into:
Whole Exome Sequencing
Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
and Whole Genome Sequencing
By Application, Next Generation Sequencing market has been segmented into:
Oncology [Diagnostics and Screening
Companion Diagnostics]
by End User (Hospitals & Clinics
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Next Generation Sequencing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Next Generation Sequencing market.
Top Key Players Covered in Next Generation Sequencing market are:
Becton Eurofins Scientific (US)
Illumina
Inc.(US)
Genome Life Sciences (India)
GenScript (US)
Thermo Fisher Scientific
Inc. (US)
Qiagen (Germany)
PerkinElmer
Inc. (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Pacific Biosciences of California
Inc.(US)
Xcelris Genomics (India)
among others
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Next Generation Sequencing Market Type
4.1 Next Generation Sequencing Market Snapshot and Growth Engine
4.2 Next Generation Sequencing Market Overview
4.3 Whole Exome Sequencing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Whole Exome Sequencing: Geographic Segmentation Analysis
4.4 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]: Geographic Segmentation Analysis
4.5 and Whole Genome Sequencing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 and Whole Genome Sequencing: Geographic Segmentation Analysis
Chapter 5: Next Generation Sequencing Market Application
5.1 Next Generation Sequencing Market Snapshot and Growth Engine
5.2 Next Generation Sequencing Market Overview
5.3 Oncology [Diagnostics and Screening
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Oncology [Diagnostics and Screening: Geographic Segmentation Analysis
5.4 Companion Diagnostics]
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Companion Diagnostics]: Geographic Segmentation Analysis
5.5 by End User (Hospitals & Clinics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 by End User (Hospitals & Clinics: Geographic Segmentation Analysis
5.6 Diagnostic Laboratories
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Diagnostic Laboratories: Geographic Segmentation Analysis
5.7 Pharmaceutical and Biotechnology Companies
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Pharmaceutical and Biotechnology Companies: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Next Generation Sequencing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BECTON EUROFINS SCIENTIFIC (US)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ILLUMINA
6.4 INC.(US)
6.5 GENOME LIFE SCIENCES (INDIA)
6.6 GENSCRIPT (US)
6.7 THERMO FISHER SCIENTIFIC
6.8 INC. (US)
6.9 QIAGEN (GERMANY)
6.10 PERKINELMER
6.11 INC. (US)
6.12 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND)
6.13 PACIFIC BIOSCIENCES OF CALIFORNIA
6.14 INC.(US)
6.15 XCELRIS GENOMICS (INDIA)
6.16 AMONG OTHERS
Chapter 7: Global Next Generation Sequencing Market By Region
7.1 Overview
7.2. North America Next Generation Sequencing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Whole Exome Sequencing
7.2.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.2.2.3 and Whole Genome Sequencing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Oncology [Diagnostics and Screening
7.2.3.2 Companion Diagnostics]
7.2.3.3 by End User (Hospitals & Clinics
7.2.3.4 Diagnostic Laboratories
7.2.3.5 Pharmaceutical and Biotechnology Companies
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Next Generation Sequencing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Whole Exome Sequencing
7.3.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.3.2.3 and Whole Genome Sequencing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Oncology [Diagnostics and Screening
7.3.3.2 Companion Diagnostics]
7.3.3.3 by End User (Hospitals & Clinics
7.3.3.4 Diagnostic Laboratories
7.3.3.5 Pharmaceutical and Biotechnology Companies
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Next Generation Sequencing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Whole Exome Sequencing
7.4.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.4.2.3 and Whole Genome Sequencing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Oncology [Diagnostics and Screening
7.4.3.2 Companion Diagnostics]
7.4.3.3 by End User (Hospitals & Clinics
7.4.3.4 Diagnostic Laboratories
7.4.3.5 Pharmaceutical and Biotechnology Companies
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Next Generation Sequencing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Whole Exome Sequencing
7.5.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.5.2.3 and Whole Genome Sequencing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Oncology [Diagnostics and Screening
7.5.3.2 Companion Diagnostics]
7.5.3.3 by End User (Hospitals & Clinics
7.5.3.4 Diagnostic Laboratories
7.5.3.5 Pharmaceutical and Biotechnology Companies
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Next Generation Sequencing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Whole Exome Sequencing
7.6.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.6.2.3 and Whole Genome Sequencing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Oncology [Diagnostics and Screening
7.6.3.2 Companion Diagnostics]
7.6.3.3 by End User (Hospitals & Clinics
7.6.3.4 Diagnostic Laboratories
7.6.3.5 Pharmaceutical and Biotechnology Companies
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Next Generation Sequencing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Whole Exome Sequencing
7.7.2.2 Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
7.7.2.3 and Whole Genome Sequencing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Oncology [Diagnostics and Screening
7.7.3.2 Companion Diagnostics]
7.7.3.3 by End User (Hospitals & Clinics
7.7.3.4 Diagnostic Laboratories
7.7.3.5 Pharmaceutical and Biotechnology Companies
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Next Generation Sequencing Scope:
|
Report Data
|
Next Generation Sequencing Market
|
|
Next Generation Sequencing Market Size in 2025
|
USD XX million
|
|
Next Generation Sequencing CAGR 2025 - 2032
|
XX%
|
|
Next Generation Sequencing Base Year
|
2024
|
|
Next Generation Sequencing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Becton Eurofins Scientific (US), Illumina, Inc.(US), Genome Life Sciences (India), GenScript (US), Thermo Fisher Scientific, Inc. (US), Qiagen (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California, Inc.(US), Xcelris Genomics (India), among others.
|
|
Key Segments
|
By Type
Whole Exome Sequencing
Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing]
and Whole Genome Sequencing
By Applications
Oncology [Diagnostics and Screening
Companion Diagnostics]
by End User (Hospitals & Clinics
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
|
